Oxidative stress and vascular damage in hypertension
Metabolism of oxygen by cells generates potentially deleterious reactive oxygen species, including superoxide anion radical, hydrogen peroxide, and hydroxyl radical. Under normal physiologic conditions the rate and magnitude o oxidant formation is balanced by the rate of oxidant elimination. However, an imbalance between prooxidants and antioxidants results in oxidative stress, which is the pathogenic outcome of the overproduction of oxidants that overwhelms the cellular antioxidant capacity. There is increasing evidence that an elevation of oxidative stress and associated oxidative damages are mediators of vascular injury in various cardiovascular pathologies, including hypertension, atherosclerosis, and ischemia-reperfusion. This review focuses on the vascular effects of reactive oxygen species and the role of oxidative stress in vascular damage in hypertension.
KeywordsReactive Oxygen Species Vascular Smooth Muscle Cell NADPH Oxidase Vascular Damage Human Vascular Smooth Muscle Cell
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Touyz RM, Schiffrin EL: Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999, 34(Part 2):976–982. The first study to show that phospholipase D-dependent pathways regulate NADH/NADPH oxidase-generated superoxide in human vascular smooth muscle cells.PubMedGoogle Scholar
- 5.Harrison DG: Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997, 2153–2157. An excellent review on the mechanisms that impair endotheliumdependent function.Google Scholar
- 8.Laursen JB, Rajagopalan S, Galis Z, et al.: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997, 95:588–593. The first in-depth study to demonstrate a link between angiotensin II-induced hypertension and oxidative stress. This study also shows that superoxide plays a role in angiotensin II-induced hypertension but not in norepinephrine-induced hypertension.PubMedGoogle Scholar
- 11.Schnackenberg CG, Welch W, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 1999, 32:59–64.Google Scholar
- 12.Chappel LC, Seed PT, Briley AL, et al.: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999, 354:810–816.Google Scholar
- 18.Griendling KK, Ushio-Fukai M: NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 1997, 301–307. Excellent review on the structure, function and regulation of the vascular NADH/NADPH oxidase system.Google Scholar
- 22.Azumimi H, Inoue N, Takeshita S, et al.: Expression of NADH/ NADPH oxidase p22phox in human coronary arteries. Circulation 1999, 100:1494–1498.Google Scholar
- 23.Marumo T, Schini-Kerth VB, Brandes RP, Busse R: Glucocorticoids inhibit superoxide anion production and p22phox mRNA expression in human aortic smooth muscle cells. Hypertension 1999, 32:1083–1088.Google Scholar
- 24.Suh YA, Arnold RS, Lassegue B, et al.: Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 410:79–82. The first study to demonstrate that mox1 is expressed in nonphagocytic cells, and that it may be the vascular counterpart of neutrophil gp91phox.Google Scholar
- 26.De Keulener GW, Alexander RW, Ushio-Fukai M: Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998, 329:653–657.Google Scholar
- 38.Fukai T, Siegfried MR, Ushio-Fukai M, et al.: Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 1999, 85:23–28. This paper clearly demonstrates that in hypertension, Ang II induces upregulation of vascular superoxide dismutase expression and activity.PubMedGoogle Scholar